Health Care · Health Care Technology
Solventum: revenue, profit and cash flow
In fiscal 2025, Solventum had revenue of $8.32B and net income of $1.56B (18.7% of revenue).
Revenue, fiscal 2025
change from fiscal 2024
- Ticker
- SOLV · NYSE
- Sector
- Health Care
- Sub-industry
- Health Care Technology
- Headquarters
- Saint Paul, Minnesota
- Founded
- 2023
- In the S&P 500 since
- April 1, 2024
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- Solventum Corp · CIK 0001964738
Revenue and net income
Revenue went from $8.13B in 2022 to $8.32B in 2025.
Diluted earnings per share
Diluted EPS went from $7.78 in 2022 to $8.88 in 2025.
Shares outstanding
From 173M in 2022 to 175M in 2025.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was −$10M in 2025, −0.1% of revenue. Negative in 2025.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|
| 2025 | $8.32B | $1.56B | 18.7% | $8.88 | 175M | $369M | $379M | −$10M |
| 2024 | $8.25B | $479M | 5.8% | $2.76 | 174M | $1.19B | $380M | $805M |
| 2023 | $8.2B | $1.35B | 16.4% | $7.79 | 173M | $1.92B | $290M | $1.62B |
| 2022 | $8.13B | $1.34B | 16.5% | $7.78 | 173M | $1.68B | $251M | $1.43B |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
About these figures
- No dividends per share in the filings data. Usually that means no dividend, but some companies report theirs in a form the data do not capture.
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Health Care Technology companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.